Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells()()

Anaplastic thyroid cancer (ATC) constitutes less than 2% of total thyroid cancers but accounts for 20–40% of thyroid cancer-related deaths. Cancer stem cell drug resistance represents a primary factor hindering treatment. This study aimed to develop targeted agents against thyroid malignancy, focusi...

詳細記述

保存先:
書誌詳細
出版年:Neoplasia
主要な著者: Lee, Yong Sang, Kim, Seok-Mo, Kim, Bup-Woo, Chang, Ho Jin, Kim, Soo Young, Park, Cheong Soo, Park, Ki Cheong, Chang, Hang-Seok
フォーマット: Artigo
言語:Inglês
出版事項: Neoplasia Press 2018
主題:
Original article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5767911/
https://ncbi.nlm.nih.gov/pubmed/29331886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2017.12.003
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料